INS and Hypoglycemia: This dearth of information may be attributable to past barriers for diabetic pilots to operate commercials flights due to the risk of incapacitation from hypoglycemia while flying, yet recent advances in insulin therapies, monitoring techniques, and modes of administration have given rise to policy developments reducing barriers for diabetic pilots to operate commercial flights [70].